The relation between n-3 polyunsaturated fatty acid (PUFA) and nonfatal myocardial infarction is still controversial.
difference in plasma fish oil levels between patients with myocardial infarction and controls in a prospective nested case-control study (the Physician's Health Study). 3) Soderberg, et al reported that the combination of high leptin and low apo A-1 was associated with a particularly pronounced increased risk for AMI among male subjects in a region with a high incidence of cardiovascular disease. 6) Wallace, et al also reported in the large prospective West of Scotland Coronary Prevention Study (WOSCOPS) that leptin is a novel, independent risk factor for coronary heart disease in hypercholesterolemic males. 7) Leptin is a pleiotropic hormone 8) exerting diverse actions via its receptors in the hypothalamus and peripheral tissues. 9) Among these actions, recent interest has focused on its cardiovascular actions. Leptin stimulates vascular smooth muscle cell proliferation and migration, 10) enhances vascular calcification, 11) induces oxidative stress in endothelial cells, 12, 13) induces hypertrophy in cultured cardiomyocytes, 14) and promotes vascular remodeling and neointimal growth, possibly, via its receptors in the intimal lesion. 15) Hyperleptinemia is associated with poor arterial compliance, 16) myocardial hypertrophy, 17) chronic heart failure, 18) essential hypertension, 19) and stroke. 20) Furthermore, there is a strong positive relationship between leptin and CRP, 21) implicating leptin as a factor that promotes vascular inflammation. These diverse actions of leptin suggest it is not only a novel risk factor, but also a major causal link for cardiovascular diseases, as is CRP. 22, 23) Plasma leptin levels are reported to be elevated in nonobese persons with insulin resistance 24) which is related to metabolic syndrome, and the intracellular signaling pathways of insulin and leptin are interrelated. 25) Leptin resistance [26] [27] [28] [29] [30] [31] is a complex pathophysiological concept. However, it could be summarized as follows; 1) restricted transport capacity of the hormone across the blood-brain barrier, 28) 2) selective derangement of anorectic signals of the hormone in the hypothalamus preserving sympatho-excitatory pathways including hypertensive effects, 29) and 3) selective depression of pathways promoting fatty acid oxidation in the peripheral organs such as the liver 27) and skeletal muscle, 30) or selective resistance at the adipocyte level, 31) not ameliorating adverse cardiovascular effects including the direct atherogenic action of hyerleptinemia. 15) Although there is no simple reliable clinical marker for insulin resistance, plasma leptin levels, which represent leptin resistance, [26] [27] [28] [29] [30] [31] can be readily measured. In the current multicenter case-control pilot study on n-3 PUFA in Niigata prefecture, where the incidence of coronary disease is low, we measured serum total fatty acid composition and leptin levels, and found that n-3 PUFA and leptin may be risk factors for AMI. 
METHODS

Subjects:
The study was carried out in Niigata prefecture, which is located in central Japan. Patients with AMI ranging in age from 40 to 80 years old (n = 73) and age-and gender-matched control persons (n = 84) were recruited at the hospitals listed in the Appendix. Patients with diabetes mellitus (FBS > 140), an atherosclerotic cardiovascular disease (old myocardial infarction, angina pectoris, cerebrovascular disease, peripheral vascular disease) or a history of any of these diseases were excluded from the control group. Written informed consent was obtained from all subjects. The ethics committee of each hospital approved the study. Measurements: Fasting blood samples were obtained from all subjects. Blood samples were obtained in the morning following admission for AMI. Body height and weight, blood pressure, and serum total cholesterol (T chol), triglyceride (TG), and HDL cholesterol (HDLc) levels were measured at each hospital. Serum total fatty acids, leptin, and high-sensitivity CRP were measured by a commercial laboratory in Japan (SRL Inc.). Serum total fatty acids were measured using Omegawax 250 (SUPELCO, gas-chromatography), leptin using HUMAN LEP-TIN RIA KIT (LINCO Research Inc.), and high-sensitivity CRP using N-latex CRP (DADE BEHRING). Smoking history was obtained from each person. Statistical analysis:The numerical values are presented as the mean ± SD. Group comparisons were conducted using an unpaired t test. Categorical variables were compared using the χ 2 test. Correlations were analyzed using Pearson's product moment correlation coefficients and Fisher's z-transformation. P values less than 0.05 were considered to be significant. The relative significances of BMI, leptin, TG, T chol, and HDLc were examined by logistic regression analysis.
RESULTS
Clinical data:
The baseline characteristics and laboratory data of the patients and control subjects are presented in Table I . There were no statistically significant differences in BMI, TG, or T chol between the cases and controls. Leptin and HDLc: Significant differences were found in leptin and HDLc between the two groups ( Table I) . The difference in serum leptin was significant when males and females were analyzed separately (Table I) . Although leptin and BMI were closely correlated (P < 0.0001), there was no significant difference in BMI between the cases and controls (P = 0.173). In logistic regression analysis, BMI, TG, and T chol were discarded as independent variables (β = -0.117, -0.004, -0.00015, respectively, and P = 0.127, 0.308, 0.985, respectively), though HDLc and leptin were adopted as independent variables (β = -0.099 and +0.132, respectively, and P = 0.00003 and 0.037, respectively). Fatty acid composition: Serum levels (weight%) of lauric acid (C12:0), myristic acid (C14:0), stearic acid (C18:0), linolenic acid (C18:3:n3), eicosenic acid (C20:1:n9), eicosapentaenoic acid (EPA, C20:5:n3), docosapentaenoic acid (C22:5:n3), and total n-3 PUFA were significantly lower, and those of palmitic Distribution of n-3/n-6 PUFA ratio in AMI and control groups. An n-3/ n-6 PUFA ratio higher than 0.3 favored the control group (P < 0.05 χ acid (C16:0), oleic acid (C18:1:n9), arachidic acid (C20:0), and dihomo-γ-linolenic acid (C20:3:n6) were significantly higher in patients with AMI than the control group (Table II) . The serum n-3 PUFA/saturated fatty acid (SF) ratio and n-3 PUFA/n-9 monounsaturated fatty acid (MUFA) ratio were significantly lower in patients with AMI than the controls (Table II , P < 0.05 and < 0.01, respectively). When the subjects were divided into two categories according to the serum n-3/ n-6 PUFA ratio; those lower than 0.3 and those above 3, patients with AMI were more frequently in the former while the controls were more frequently in the latter (Figure 1 , P < 0.05).
DISCUSSION
Although this is a pilot study and the number of subjects is rather small, significant differences were found in serum levels of n-3 PUFA, leptin, and HDLc between the AMI patients and the control group. Even though the study populations were completely different, the present results are strikingly similar to those reported by Söderberg, et al 6) in that the most pronounced differences between the AMI and control groups were seen in the levels of leptin and HDLc, though they measured apo A-1 instead of HDLc for a technical reason. Also, in the report by Wallace, et al, 7) the differences in leptin (P < 0.0001) and HDLc (P < 0.0001) between the AMI and control groups were bigger than those in T chol (NS) and TG (P < 0.01). These previous two reports included no female subjects and were performed on populations in countries with high incidences of AMI. In contrast, the present study was performed in a population with a low incidence of AMI and included female subjects. When analyzed separately by gender, statistically significant differences in leptin and HDLc between patients with AMI and controls were also found among women. Therefore, leptin and HDLc may be strong risk factors for myocardial infarction irrespective of ethnicity and gender. However, our study is a cross sectional study and serum T chol, TG, HDLc, and leptin levels may be influenced by acute reactions following AMI. Therefore, further prospective studies are required.
Although protection against sudden death by n-3 PUFA has been established both among men with and without previous myocardial infarction (MI), 1, 2) the relationship between n-3 PUFA and nonfatal MI is controversial. [3] [4] [5] In the present study, we found significantly lower n-3 PUFA levels in %weight and lower n-3 PUFA/SF and n-3 PUFA/n-9 MUFA ratios in AMI subjects than in the controls in a population with higher n-3/n-6 PUFA ratios than those in Western countries, where the n-3/n-6 PUFA ratio is approximately 0.1. When the subjects were divided into two categories according to the serum n-3/n-6 PUFA ratio; less than 0.3 or greater than 0.3; patients with AMI were more frequently in the former while the controls were more frequently in the latter. From cross-sectional analysis of contemporary hunter-gatherer populations, it has been estimated that the n-3/n-6 PUFA ratio in the human diet has been close to 1.0 during the 2-4 million years of human existence during which our genes adapted to the environment, including diet. 32) Therefore, it is possible that the optimal value of the n-3/n-6 PUFA ratio may be higher than 0.3. Guallar, et al reported that there was no difference in plasma fish oil levels between patients with myocardial infarction and controls.
3) The n-3/n-6 PUFA ratio of their subjects may have been lower than the threshold. Winnicki, et al reported that a diet rich in fish is associated with lower plasma leptin, independent of body fat.
33) However, we were unable to verify an inverse correlation between leptin and the n-3/n-6 PUFA ratio. Limitations: The present study was a cross-sectional case-control study, and serum levels of T chol, TG, HDLc, leptin, and fatty acids may have been influenced by acute reactions and prolonged fasting in the AMI group. Therefore, the present results may merely reflect the results of AMI, not the risks for AMI. However, our results are strikingly similar to the data reported by Soderberg, et al 6) and Wallace, et al, 7) both of which were prospective nested case-control studies. Nevertheless, this concern should be resolved by further prospective studies.
Conclusion:
The results of the present study indicate that relative serum levels of n-3 PUFA were significantly lower in patients with AMI than in controls and that the serum level of leptin was significantly higher in patients with AMI than in controls irrespective of gender. Serum n-3 PUFA levels may be a negative risk factor for AMI, however, further studies are still warranted. 
